Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy.
Niimura M, Sakamoto Y, Shimoda M, Harada N, Maeda A, Wada S, Murata K, Thinyakul C, Liu S, Ohara H, Iwamoto A, Kanamori Y, Nita A, Wakao M, Suda Y, Oshiumi H, Hayashi T, Carson DA, Shinchi H, Moroishi T.
Niimura M, et al. Among authors: carson da.
Commun Med (Lond). 2025 Aug 29;5(1):378. doi: 10.1038/s43856-025-01102-3.
Commun Med (Lond). 2025.
PMID: 40883594
Free PMC article.